United States Respiratory Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 100 Pages I Mordor Intelligence
United States Respiratory Devices Market Analysis
The United States Respiratory Devices Market size is estimated at USD 9.75 billion in 2025, and is expected to reach USD 12.63 billion by 2030, at a CAGR of 5.32% during the forecast period (2025-2030). Demand growth follows rising chronic respiratory disease prevalence, an aging population that prefers treatment at home, and the Centers for Medicare & Medicaid Services (CMS) widening reimbursement for home oxygen therapy and non-invasive ventilation. Intensifying wildfire seasons, particularly in western states, elevate consumer interest in air-purifying respiratory products, while artificial-intelligence (AI) algorithms embedded in diagnostic tools speed time-to-care and improve clinical accuracy. Concurrently, recall-driven quality scrutiny compels manufacturers to invest in safer materials and smarter sensors, sharpening the competitive focus on patient safety. Moderate industry consolidation persists as leading brands acquire digital-health start-ups to integrate hardware, software, and data analytics into unified care platforms.
United States Respiratory Devices Market Trends and Insights
Rising COPD & Asthma Prevalence Among U.S. Adults
COPD affects 12.5 million diagnosed adults and asthma affects 26.8 million Americans, with prevalence peaking in southeastern and midwestern counties. State-level COPD rates vary from 3% in Hawaii to 12% in West Virginia, mirroring disparities in environmental exposures and healthcare access. COPD mortality spans 41-171 deaths per 100,000 adults, underscoring the ongoing therapeutic burden. These epidemiologic patterns fuel demand for nebulizers, oxygen concentrators, and digital inhalers capable of predicting exacerbations by monitoring inspiratory flow metrics. Annual direct and indirect asthma costs near USD 80 billion, intensifying payer interest in cost-effective home-based respiratory solutions.
Aging Demographics and Home-care Shift
Nearly one quarter of Americans will be 65 years or older by 2060, prompting a structural shift toward in-home therapy and remote patient monitoring. Medicare beneficiaries recorded over 240k COPD-related hospitalizations in recent times, amplifying the need for portable oxygen concentrators and home ventilators. Remote patient monitoring users already number about 50 million and are expected to double by the end of the decade as reimbursement aligns with value-based care incentives. The Patient-Driven Groupings Model increases operational complexity but rewards providers that demonstrate measurable outcome improvements using connected respiratory platforms. Long-term mechanical ventilation cases more than doubled over two decades, tightening capacity in post-acute facilities and driving investment in home-compatible ventilators.
High Up-front Cost & Hospital Capital Budget Cycles
Most U.S. hospitals allocate major equipment purchases once per fiscal year, extending replacement decisions 12-18 months and deferring acquisition of advanced ventilators and imaging-grade ultrasound devices. A 2.93% payment cut in the 2025 Physician Fee Schedule compresses operating margins, especially in rural facilities with thin cash reserves. Value-based reimbursement requires clear clinical-outcome evidence for capital requests, raising the bar for device makers to supply real-world data. Although COPD's annual economic toll nears USD 50 billion, the longer payback period for sophisticated diagnostics can slow adoption, particularly where patient volumes are modest. Manufacturers offer leasing and per-use subscription models to mitigate sticker shock, but uptake remains mixed outside large health systems.
Other drivers and restraints analyzed in the detailed report include:
CMS Reimbursement Expansion for Home Oxygen Therapy & NIV / Uptake of Smart, Connected Respiratory Devices via Tele-health / Stringent FDA Approval Timelines /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic devices commanded 46.54% of the 2024 United States respiratory devices market, anchored by positive airway pressure (PAP) systems and home ventilators that address both chronic and acute conditions. The installed base generates high-margin consumables demand, while AI-driven adherence algorithms elevate therapeutic efficacy. Diagnostic & monitoring devices remain the fastest-growing category at a 6.65% CAGR through 2030 as FDA-cleared home-use spirometers and AI auscultation software migrate testing from clinics to living rooms. Disposables retain steady uptake because masks, filters, and breathing circuits require periodic replacement, ensuring recurring revenue.
A key growth inflection stems from vibrating mesh nebulizers that deliver superior deposition in COPD therapy, prompting formulary inclusion by major payers. Portable oxygen concentrators integrate cloud connectivity, allowing clinicians to titrate flow remotely and aligning with home-care trends. Diagnostic smart patches that track respiratory rate and sleep motion shorten sleep-apnea diagnosis cycles. Combined, these factors add incremental value to the United States respiratory devices market size while intensifying competition around data-driven user experiences.
The United States Respiratory Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic Devices, Disposables), Indication (COPD, Asthma, Sleep Apnea, Infectious Diseases, Other Respiratory Disorders), End User (Hospitals & Clinics, Home-Care Settings, and More), and Geography (Northeast, Midwest, Southeast, West, Southwest). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Koninklijke Philips / Resmed / Fisher & Paykel Healthcare / Medtronic / GEHealthcare / Dragerwerk AG / Getinge / Baxter / Vyaire Medical / Hamilton Medical / Beijing Aeonmed Co. Ltd. / Mindray / React Health / Medical Depot, Inc. / Asahi Kasei / AirLife / Flexicare (Group) Limited (Allied Medical LLC) / Teleflex / OMRON Healthcare, Inc / ICU Medical /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising COPD & Asthma Prevalence Among U.S. Adults
4.2.2 Aging Demographics and Home-care Shift
4.2.3 CMS Reimbursement Expansion for Home Oxygen Therapy & NIV
4.2.4 Uptake of Smart, Connected Respiratory Devices via Tele-health
4.2.5 Growth of Ambulatory Surgical Centers Driving Portable Ventilation
4.2.6 Wild-fire Smoke Episodes Elevating Home Airway-Care Demand
4.3 Market Restraints
4.3.1 High Up-front Cost & Hospital Capital Budget Cycles
4.3.2 Stringent FDA Approval Timelines
4.3.3 Recalls & Safety Concerns Undermining Brand Trust
4.3.4 Limited Awareness of Early Diagnosis
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 Spirometers
5.1.1.2 Sleep Test Devices
5.1.1.3 Peak Flow Meters
5.1.1.4 Pulse Oximeters
5.1.1.5 Capnographs
5.1.1.6 Other Diagnostic & Monitoring Devices
5.1.2 Therapeutic Devices
5.1.2.1 CPAP Devices
5.1.2.2 BiPAP Devices
5.1.2.3 Humidifiers
5.1.2.4 Nebulizers
5.1.2.5 Oxygen Concentrators
5.1.2.6 Ventilators (Invasive, Non-invasive)
5.1.2.7 Inhalers (MDI, DPI, Soft-Mist)
5.1.2.8 Other Therapeutic Devices
5.1.3 Disposables
5.1.3.1 Masks (CPAP, Oxygen, Nebulizer)
5.1.3.2 Breathing Circuits
5.1.3.3 Filters & Cannulas
5.1.3.4 Other Disposables
5.2 By Indication
5.2.1 COPD
5.2.2 Asthma
5.2.3 Sleep Apnea
5.2.4 Infectious Diseases
5.2.5 Other Respiratory Disorders
5.3 By End User
5.3.1 Hospitals & Clinics
5.3.2 Home-care Settings
5.3.3 Ambulatory Surgical Centers
5.3.4 Emergency & Trauma Centers
5.3.5 Long-Term Care Facilities
5.4 By Region
5.4.1 Northeast
5.4.2 Midwest
5.4.3 Southeast
5.4.4 West
5.4.5 Southwest
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Koninklijke Philips N.V.
6.3.2 ResMed
6.3.3 Fisher & Paykel Healthcare Ltd
6.3.4 Medtronic plc
6.3.5 GE HealthCare
6.3.6 Dragerwerk AG
6.3.7 Getinge
6.3.8 Baxter
6.3.9 VYAIRE
6.3.10 Hamilton Medical
6.3.11 Beijing Aeonmed Co. Ltd.
6.3.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.3.13 React Health
6.3.14 Medical Depot, Inc.
6.3.15 Asahi Kasei Corporation (ZOLL Medical Corporation)
6.3.16 AirLife
6.3.17 Flexicare (Group) Limited (Allied Medical LLC)
6.3.18 Teleflex Incorporated
6.3.19 OMRON Healthcare, Inc
6.3.20 ICU Medical, Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.